Overview
Status
Active
Registry date
2012-11-10
Share capital
5 000,00 PLN
Registered address
Świętojańska 4/6/3, 00-288 Warszawa, Poland
Website
Email
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 465 days for 2022).
- 202509/07/2026
- 202410/07/2025
- 202306/12/2024
- 202222/10/2024
- 202129/06/2022
- 202015/06/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 1.43mMedianUSD 115.65kAverageUSD 1.11m
Net profit
This companyUSD 129.23kMedianUSD 4.00kAverageUSD 74.50k
Operating costs
This companyUSD 1.27mMedianUSD 100.69kAverageUSD 1.01m
Assets
This companyUSD 640.69kMedianUSD 57.38kAverageUSD 668.67k
Industry
Trademarks
Pharmaceutica holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2021.
| Mark | Protected until | |
|---|---|---|
| pharmedio.pl(word) | Sep 16, 2031 |
Authorized Representatives
Artur Schab – Management Board Member
Tomasz Grzegorz Barałkiewicz – Management Board Member
Manner of representation
Each member of the management board is authorised to make declarations and sign on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Tomasz Grzegorz Barałkiewiczage 48 | 50 | $675.31 | 50% |
Artur Schabage 53 | 50 | $675.31 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2013-02-01.
39 1030 0019 0109 7860 1010 3182
08 1140 2004 0000 3302 8688 7466
78 1030 0019 0109 8530 0046 0924
Debt
No entries in the National Debtors Register (KRZ).
Public aid
5 public aid cases recorded, with a total value of $7,912.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 2, 2021 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $4,657$4,657 | Polski Fundusz Rozwoju S.A. | |
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $632$632 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Aug 4, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $769$769 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Adprimesp. z o.o. | $1,793,032.49 | adprime.pl | ||
| JBSS.A. | $1,732,047.79 | jbs.waw.pl | ||
| Arianpolsp. z o.o. | $745,821.44 | arianpol.eu | ||
| Bggasp. z o.o. | $726,042.48 | bgga.pl | ||
| Wirelesscomsp. z o.o. | $660,521.74 | rainbowcups.eu | ||
| Prenatalissp. z o.o. | $600,793.01 | prenatalis.com.pl | ||
| POVsp. z o.o. | $528,335.29 | pointofview.pl | ||
| Studio Artissp. z o.o. | $55,909.63 | studioartis.pl | ||
| Bizarresp. z o.o. | $48,990.69 | bizarre.com.pl | ||
| Solidartsp. z o.o. | $46,876.98 | solidart.pl |
Change history
| Date | Event | |
|---|---|---|
| 2015-02-16 | Name change (Top Brands → Pharmaceutica) | |
| 2015-02-16 | PKD change (Removed: 46.16.Z, 46.17.Z, 46.33.Z, 46.36.Z, 46.39.Z, 46.46.Z, 46.51.Z, 47.11.Z, 47.61.Z, 47.73.Z, 47.74.Z, 47.91.Z, 58.11.Z, 58.13.Z, 58.14.Z, 63.11.Z, 63.12.Z, 69.20.Z, 70.21.Z, 70.22.Z, 73.12.A, 73.12.B, 73.12.D, 78.10.Z, 82.20.Z, 82.30.Z, 86.90.E) | |
| 2012-11-10 | Entered in the register |
FAQ
The main business activity of Pharmaceutica focuses on advertising agencies.
The company was registered in the Polish National Court Register (KRS) on November 10, 2012.
The headquarters is located at: Świętojańska 4/6, 00-288 Warszawa.
The management board consists of: Artur Schab (Member of the Management Board) and Tomasz Grzegorz Barałkiewicz (Member of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $1,121,145 in 2024, which is an increase of 47.0% compared to 2023.
Yes, in 2024 the company was profitable, achieving a net profit of $212,503, meaning the company increased its profit by 133.6%.
The largest operating cost category falls under external services. This category amounted to $826,547 in 2024, representing 94% of all operating expenses.
Last updated: 2026-07-15